IJCS | Volume 31, Nº6, November / December 2018

592 1. Garcia-Alvarez A, Sitges M, Pinazo MJ, Regueiro-Cueva A, Posada E, Poyatos S, et al. Chagas cardiomyopathy: the potential of diastolic dysfunction and brain natriuretic peptide in the early identification of cardiac damage. PLoS Negl Trop Dis. 2010;4(9). pii: e826. 2. Rassi A Jr, Rassi A, Marin-Neto JA. Chagas disease. Lancet. 2010;375(9723):1388-402. 3. World Health Organization. Research priorities for Chagas disease, human African trypanosomiasis and leishmaniasis. WorldHealth Organ Tech Rep Ser. 2012;(975):v-xii, 1-100. 4. Bocchi EA, Bestetti RB, Scanavacca MI, Cunha Neto E, Issa VS. Chronic Chagas heart disease management: from etiology to cardiomyopathy treatment. J Am Coll Cardiol. 2017;70(12):1510-24. 5. Nogueira PR, Rassi S, Corrêa Kde S. Epidemiological, clinical and therapeutic profile of heart failure in a tertiary hospital. Arq Bras Cardiol. 2010;95(3):392-8. 6. Rassi A Jr, Rassi A, Little WC. Chagas’'s heart disease. Clin Cardiol. 2000;23(12):883-9. 7. Marques DS, Canesin MF, Barutta Júnior F, Fuganti CJ, Barretto AC. Evaluation of asymptomatic patients with chronic Chagas disease through ambulatory electrocardiogram, echocardiogram and B-Type natriuretic peptide analyses. Arq Bras Cardiol. 2006;87(3):336-43. 8. Cavallini G, Clerico A, Del Chicca M, Gori Z, Bergamini E. Changes in endocrine atrial rat cardiocytes during growth and aging: an ultrastructural, morphometric and endocrinological study. Aging (Milano). 1994;6(3):167-74. 9. Federico C. Natriuretic peptide systemand cardiovascular disease. Heart Views. 2010;11(1):10-5. 10. Klaiber M, Dankworth B, Kruse M, Hartmann M, Nikolaev VO, Yang RB, et al. A cardiac pathway of cyclic GMP-independent signaling of guanylyl cyclase A, the receptor for atrial natriuretic peptide. Proc Natl Acad Sci U S A. 2011;108(45):18500-5. 11. Sudoh T, Kangawa K, MinaminoN, MatsuoH. Anewnatriuretic peptide in porcine brain. Nature. 1988;332(6159):78-81. 12. da Silva LB, Ferreira, CA Blacher C, Leães P, Haddad H. [B-type natriuretic peptide and cardiovascular disease]. Arq Bras Cardiol. 2003;81(5):529-34. 13. Talvani A, Rocha MO, Cogan J, Maewal P, de Lemos J, Ribeiro AL, et al. Brain natriuretic peptide and left ventricular dysfunction in Chagas’ic cardiomyopathy. Mem Inst Oswaldo Cruz. 2004;99(6):645-9. 14. Daniels LB, Maisel AS. Natriuretic peptides. J Am Coll Cardiol. 2007;50(25):2357-68. 15. Binder J, Ommen SR, Chen HH, Ackerman MJ, Tajik AJ, Jaffe AS. Usefulness of brain natriuretic peptide levels in the clinical evaluation of patients with hypertrophic cardiomyopathy. Am J Cardiol. 2007;100(4):712-4. 16. McGrath MF, de Bold ML, de Bold AJ. The endocrine function of the heart. Trends Endocrinol Metab. 2005;16(10):469-77. 17. Bianchi C, Gutkowska J, Thibault G, Garcia R, Genest J, Cantin M. Radioautographic localization of 125I-atrial natriuretic factor (ANF) in rat tissues. Histochemistry. 1985;82(5):441-52. 18. Goodman JM, Logan AG, McLaughlin PR, Laprade A, Liu PP. Atrial natriuretic peptide during acute and prolonged exercise in well-trained men. Int J Sports Med. 1993;14(4):185-90. 19. Roffe C. Ageing of the heart. Br J Biomed Sci. 1998;55(2):136-48. 20. Silva LH, Nussenzweig V. Sobre uma cepa de Trypanosomacruzi altamente virulenta para o camundongo branco. Folia Clin Biol. 1953;20:191-203 21. Brener Z. Therapeutic activity and criterion of cure on mice experimentally infected with Trypanosomacruzi. Rev Inst Med Trop Sao Paulo. 1962 Nov-Dec;4:389-96. 22. Lancha AH Jr, Poortmans JR, Pereira LO. The effect of 5 days of aspartate and asparagine supplementation on glucose transport activity in rat muscle. Cell Biochem Funct. 2009;27(8):552-7. 23. Mandarim-de-Lacerda CA. Stereological tools in biomedical research. An Acad Bras Cienc. 2003;75(4):469-86. Erratum in: An Acad Bras Cienc. 2007;79(1):51. 24. AretzHT. Myocarditis: the Dallas criteria. HumPathol. 1987;18(6):619-24. 25. Preto E, Lima NE, Simardi L, Fonseca FL, Filho AA, Maifrino LB. Effect of mild aerobic training on the myocardiumof mice with chronic Chagas disease. Biologics. 2015 Sep 23;9:87-92. 26. McGrath MF, De Bold ML, De Bold, AJ. The endocrine function of the heart. Trends Endocrinol Metab. 2005;16(10):469-77. 27. Clerico A, Carlo Zucchelli G, Pilo A, Passino C, Emdin M. Clinical relevance of biological variation: the lesson of brain natriuretic peptide (BNP) and NT-proBNP assay. Clin Chem Lab Med. 2006;44(4):366-78. 28. Capoulade R, Magne J, Dulgheru R, Hachicha Z, Dumesnil JG, O'Connor K, et al. Prognostic value of plasma B-type natriuretic peptide levels after exercise in patients with severe asymptomatic aortic stenosis. Heart. 2014;100(20):1606-12. 29. Moro C, Crampes F, Sengenes C, De Glisezinski I, Galitzky J, Thalamas C, et al. Atrial natriuretic peptide contributes to physiological control of lipid mobilization in humans. FASEB J. 2004;18(7):908-10. 30. Lafontan M, Moro C, Sengenes C, Galitzky J, Crampes F, Berlan M. An unsuspected metabolic role for atrial natriuretic peptides: the control of lipolysis, lipidmobilization, and systemic nonesterified fatty acids levels in humans. Arterioscler Thromb Vasc Biol. 2005;25(10):2032-42. References Ferraboli et al. Effect of mild aerobic exercise in Chagas’disease Int J Cardiovasc Sci. 2018;31(6)585-593 Original Article content: Ferraboli R, Ornelas EM, Fonseca FLA, Veiga GL, Cardoso CG, Marques MR, Maifrino LBM. Potential Conflict of Interest No potential conflict of interest relevant to this article was reported. Sources of Funding There were no external funding sources for this study. Study Association This article is part of the thesis of master submitted by Roberto Ferraboli, from Universidade São Judas Tadeu . Ethics approval and consent to participate This study was approved by the Ethics Committee on Animal Experiments of the Universidade São Judas Tadeu (060/2007) under the protocol number 060/2007 the National Institutes of Health (Publication No. 96–23, Revised 1996).